Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South Africa

View through CrossRef
Abstract Background The World Health Organization–approved Xpert MTB/XDR test detects Mycobacterium tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and injectable drugs directly in specimens. This pragmatic, laboratory-based study assessed the diagnostic accuracy and feasibility of a reflex testing approach, where Xpert MTB/XDR was performed on residual specimens previously processed for Xpert MTB/RIF Ultra. Methods Routine respiratory specimens, processed for Xpert MTB/RIF Ultra, were stored in sample reagent buffer at 2°C–8°C. If rifampicin resistant, the residual specimen was assessed for adequate volume (≥2 mL) and tested with Xpert MTB/XDR, with storage time recorded. A second specimen was used for routine and reference standard testing (culture and sequencing). Results Specimens (99% sputum) from 763 participants submitted to 2 large routine laboratories were included. Xpert MTB/XDR yielded valid resistance detection results in 639 (84%), compared with 507 (66%) for routine testing (difference [95% CI], 18% [13%–22%]). The median turnaround time for results was 23 hours for Xpert MTB/XDR and 15 days for routine testing. While 748 specimens (98%) were ≥2 mL, only 102 (13%) were stored for ≤4 hours. By the reference standard, 284 of 394 (72%) were isoniazid resistant, and 57 of 380 (15%) were fluroquinolone resistant. The sensitivities of Xpert MTB/XDR were 94% (95% CI, 91%–97%) for isoniazid and 91% (81%–97%) for fluoroquinolone resistance detection. The specificities were 98% (94%–100%) and 100% (98%–100%), respectively. Conclusions Xpert MTB/XDR performed favorably compared with the reference, and the reflex testing approach increased results availability over routine testing, while dramatically decreasing turnaround time from weeks to hours. Laboratory workflow precluded testing within the manufacturer-recommended 4-hour storage time, but longer storage did not appear detrimental.
Oxford University Press (OUP)
C M Centner R Munir E Tagliani F Rieß P Brown C Hayes T Dolby W Zemanay D M Cirillo A David S G Schumacher C M Denkinger M Ruhwald V N Leukes M P Nicol I Van der Walt G Kisten M Gumede A Mace A Brink W Stevens L Scott A Penn-Nicholson H Cox Vinzeigh Leukes Adam Penn-Nicholson Morten Ruhwald Berra Erkosar Samuel G Schumacher Sunita Singh Bernard Kivuma Muhuminu Nuru Judith Mlenge Neema Shija Deogratias Bulime Dorcas Mnzava Petro Sabuni Hosiana Temba Jamali Siru Jerry Hella Jonathan Msafiri Maja Weisser Mohamed Mbaruku Mohamed Sasamalo Alice Leonard Ambilikile Malango Annastazia Alexander Faith Komakoma Gloria Msigala Kasmir Johaness Grace Mhalu Mwajabu Hamis Priscilla Mlay Robert Ndege Sera Barasa Swalehe Masoud Theonestina Byakuzana Anange Lwilla Benedict Kayombo Chacha Mangu Christina Manyama Theodora Mbunda Elimina Siyame Issa Sabi Last Mwaipopo Nyanda Elias Ntinginya Raphael Edom Willyhelmina Olomi Delio Elisio Dinis Nguenha Edson Mambuque Joaquim Cossa Marta Cossa Neide Gomes Patricia Manjate Shilzia Munguambe Sozinho Acacio Belen Saavedra Helio Chiconela Katia Ribeiro António Machiana Bindiya Meggi Candido Azize Junior Carla Madeira Celso Khosa Claudio Bila Denise Floripes Diosdélio Malamule Sofia Viegas Belén Saavedra Carole Amroune Joanna Ehrlich Laura de la Torre Pérez Sergi Sanz Albero Garcia-Basteiro Friedrich Riess Sarah Mutuku Tejaswi Appalarowthu Leyla Larson Katharina Kranzer Michael Hoelscher Norbert Heinrich Maria del Mar Castro Noriega Claudia M Denkinger Saima Arif Daniela Maria Cirillo Elisa Tagliani Federico Di Marco Virginia Batignani Akash Malhotra David Dowdy Claudia Schacht Julia Buech Caroline Stöhr Marguerite Massinga Loembé Pascale Ondoa Nqobile Ndlovu Fumbani Brown Yonas Ghebrekristos Cindy Hayes Ilse Van der Walt Shareef Abrahams Puleng Marokane Mbuti Radebe Neil Martinson Anura David Lesley Scott Lucky Ngwenya Pedro Da Silva Reyhana Solomon Wendy Stevens Charles Abongomera Klaus Reither Leon Stieger Adrian Brink Chad M Centner Helen Cox Judi van Heerden Mark P Nicol Nchimunya Hapeela Parveen Brown Reyhana Solomon Widaad Zemanay Tania Dolby
Title: Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South Africa
Description:
Abstract Background The World Health Organization–approved Xpert MTB/XDR test detects Mycobacterium tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and injectable drugs directly in specimens.
This pragmatic, laboratory-based study assessed the diagnostic accuracy and feasibility of a reflex testing approach, where Xpert MTB/XDR was performed on residual specimens previously processed for Xpert MTB/RIF Ultra.
Methods Routine respiratory specimens, processed for Xpert MTB/RIF Ultra, were stored in sample reagent buffer at 2°C–8°C.
If rifampicin resistant, the residual specimen was assessed for adequate volume (≥2 mL) and tested with Xpert MTB/XDR, with storage time recorded.
A second specimen was used for routine and reference standard testing (culture and sequencing).
Results Specimens (99% sputum) from 763 participants submitted to 2 large routine laboratories were included.
Xpert MTB/XDR yielded valid resistance detection results in 639 (84%), compared with 507 (66%) for routine testing (difference [95% CI], 18% [13%–22%]).
The median turnaround time for results was 23 hours for Xpert MTB/XDR and 15 days for routine testing.
While 748 specimens (98%) were ≥2 mL, only 102 (13%) were stored for ≤4 hours.
By the reference standard, 284 of 394 (72%) were isoniazid resistant, and 57 of 380 (15%) were fluroquinolone resistant.
The sensitivities of Xpert MTB/XDR were 94% (95% CI, 91%–97%) for isoniazid and 91% (81%–97%) for fluoroquinolone resistance detection.
The specificities were 98% (94%–100%) and 100% (98%–100%), respectively.
Conclusions Xpert MTB/XDR performed favorably compared with the reference, and the reflex testing approach increased results availability over routine testing, while dramatically decreasing turnaround time from weeks to hours.
Laboratory workflow precluded testing within the manufacturer-recommended 4-hour storage time, but longer storage did not appear detrimental.

Related Results

Diagnostic accuracy of swab-based molecular tests for tuberculosis using novel near point-of-care platforms: A multi-country evaluation
Diagnostic accuracy of swab-based molecular tests for tuberculosis using novel near point-of-care platforms: A multi-country evaluation
SummaryBackgroundSwab-based molecular platforms that enable testing of both sputum (via swabs swirled in sputum) and tongue swabs are emerging as a promising option for more access...
Does Xpert MTB/RIF Assay Give Rifampicin Resistance Results Without Identified Mutation? Review of Cases from Addis Ababa, Ethiopia.
Does Xpert MTB/RIF Assay Give Rifampicin Resistance Results Without Identified Mutation? Review of Cases from Addis Ababa, Ethiopia.
Abstract Background: Xpert® MTB/RIF assay is currently used in Ethiopia for the rapid diagnosis of Mycobacterium tuberculosis (MTB) and mutations that confer Rifampicin res...
Does Xpert MTB/RIF Assay Give Rifampicin Resistance Results Without Identified Mutation? Review of Cases from Addis Ababa, Ethiopia.
Does Xpert MTB/RIF Assay Give Rifampicin Resistance Results Without Identified Mutation? Review of Cases from Addis Ababa, Ethiopia.
Abstract Background: Xpert MTB/RIF Assay is currently used in Ethiopia for the rapid diagnosis of Mycobacterium tuberculosis (MTB) and mutations that confer Rifampicin resi...
Quality assurance practices in tuberculosis diagnostic health facilities in Ethiopia
Quality assurance practices in tuberculosis diagnostic health facilities in Ethiopia
Introduction The quality of tuberculosis laboratory services in health facilities is a mandatory component of detecting active pulmonary TB cases and treatment follow-up. However, ...
Comparison of Interpretation between Pyrosequencing and Xpert MTB/RIF Assay in Multidrug-Resistant Tuberculosis
Comparison of Interpretation between Pyrosequencing and Xpert MTB/RIF Assay in Multidrug-Resistant Tuberculosis
Indonesia is one of the countries with the highest multidrug-resistant tuberculosis cases in the world. Rapid molecular test using the Xpert MTB/RIF assay is one of the detection m...

Back to Top